Stocktoria
Translational Development Acquisition Corp. TDAC
Translational Development Acquisition Corp. (TDAC) earns a Piotroski F-score of 2/9 (weak financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
How it ranks in Finance, Insurance & Real Estate · percentile among 1129 companies
Percentile vs other Finance, Insurance & Real Estate companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 2/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | -0.003 |
| Retained earnings / assets | -0.036 |
| EBIT / assets | -0.005 |
| Equity / liabilities | -0.994 |
Sector peers · similar-size Finance, Insurance & Real Estate companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| TDAC | Translational Development Acquisition Corp. | 2/9 | -1.21 | 44.6 | — |
| IPCX | Inflection Point Acquisition Corp. III | 3/9 | -1.27 | 713.8 | — |
| INV | Innventure, Inc. | 4/9 | -2.76 | — | — |
| INNI | Innovaro, Inc. | 1/9 | — | — | -96.4% |
| JFTH | Japan Food Tech Holdings, Inc. | 2/9 | — | — | — |
| MUFG | MITSUBISHI UFJ FINANCIAL GROUP INC | 4/9 | — | — | +9.5% |
| MFG | MIZUHO FINANCIAL GROUP INC | 4/9 | — | — | +7.6% |
All Finance, Insurance & Real Estate companies →
About Translational Development Acquisition Corp.
Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
FAQ
Is TDAC financially healthy?
Translational Development Acquisition Corp.'s Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does TDAC pay a dividend?
No, Translational Development Acquisition Corp. does not currently pay a dividend.
What is TDAC's P/E ratio?
Translational Development Acquisition Corp.'s trailing price-to-earnings (P/E) ratio is about 44.6×, based on its latest annual earnings.
Is TDAC a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Translational Development Acquisition Corp.: a Piotroski F-score of 2/9, an Altman Z″ in the distress zone, a P/E of about 44.6×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.